Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022

SELL
$8.36 - $21.08 $70,040 - $176,608
-8,378 Closed
0 $0
Q3 2021

Jun 21, 2023

BUY
$17.57 - $28.95 $147,201 - $242,543
8,378 New
8,378 $170,000
Q2 2021

Mar 30, 2023

BUY
$24.14 - $37.68 $97,911 - $152,830
4,056 Added 93.85%
8,378 $242,000
Q2 2021

Aug 16, 2021

BUY
$24.14 - $37.68 $202,148 - $315,532
8,374 Added 209350.0%
8,378 $243,000
Q1 2021

Jun 26, 2023

BUY
$27.92 - $52.5 $120,670 - $226,905
4,322 New
4,322 $126 Million
Q1 2021

May 14, 2021

SELL
$27.92 - $52.5 $120,558 - $226,695
-4,318 Reduced 99.91%
4 $126,000
Q4 2020

Jun 22, 2023

BUY
$19.0 - $57.61 $82,118 - $248,990
4,322 New
4,322 $226,000
Q4 2020

Mar 30, 2023

BUY
$19.0 - $57.61 $82,118 - $248,990
4,322 New
4,322 $226,000
Q4 2020

Feb 16, 2021

BUY
$19.0 - $57.61 $82,118 - $248,990
4,322 New
4,322 $227,000

Others Institutions Holding STTK

About Shattuck Labs, Inc.


  • Ticker STTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,382,000
  • Market Cap $47M
  • Description
  • Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...
More about STTK
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.